2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

Frailty in Older Adults: Evidence for a Phenotype

Fried, L. P., Tangen, C. M., Walston, J., Newman, A. B., Hirsch, C., Gottdiener, J., Seeman, T., Tracy, R., Kop, W. J., Burke, G., et al. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.3.m146 · Cited by 24,907

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx393 · Cited by 9,728

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430

A global clinical measure of fitness and frailty in elderly people

Rockwood, K. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.050051 · Cited by 8,968

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261

Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K. J., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B. L., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,957

Atrial fibrillation as an independent risk factor for stroke: the Framingham study

Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388

Atrial Fibrillation and Stroke

Rodríguez, J. E., & Sposato, L. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-43036-7_6

Cancer and heart failure

Farmakis, D. T., Lyon, A. R., de Boer, R. A., & Belenkov, Y. N. (2023) · doi:10.1093/med/9780198891628.003.0078

The search for the perfect antiplatelet treatment continues

Agewall, S. (2023) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvad079

Thromboembolieprophylaxe bei Vorhofflimmern

Gietzen, T., Steinborn, F., & Schade, A. (2023) · Kardiologie up2date · doi:10.1055/a-2065-1625

Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection

Yu, Y., Li, H., Liu, J., Liang, Q., Xie, J., & Sun, G. (2023) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-023-00622-4

Kardiale, perioperative Risikobeurteilung

Klein, K., & Kelm, M. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62932-1_45

VASCULAR HAEMORRHAGE CAUSES, SIGNS, AND TREATMENTS

Shaheen, J., Malik, Z. A., Gajanayake, L. G., Aigbedion, G., ilyas, F., & Rehman, A. U. (2023) · doi:10.53555/jptcp.v30i17.3784

One-Day Interruption of NOAC Is Associated with Low Risk of Periprocedural Adverse Events during Pulmonary Vein Isolation If Combined with Left Atrial Thrombus Exclusion with Computed Tomography

Piros, K., Vida, A., Szegedi, N., Perge, P., Salló, Z., Ferencz, A. B., Nagy, V. K., Herczeg, S., Ábrahám, P., Csobay-Novák, C., et al. (2024) · Life · doi:10.3390/life14010133

Médicaments cardiovasculaires

Belmin, J., Chassagne, P., & Friocourt, P. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77815-5.00083-4

Direct oral anticoagulant use in hospitalized patients with atrial fibrillation across body mass index categories: design and rationale for a retrospective cohort study

Shaikh, F., Wynne, R. M., Castelino, R. L., Inglis, S. C., Davidson, P. M., & Ferguson, C. (2024) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986241227014

Risikoreduktionsstrategien bei Patienten mit spezifischen kardiovaskulären Erkrankungen inkl. antithrombotische Therapie vor und nach nicht kardialen Operationen

Kluthke, R., & Perings, C. (2024) · Aktuelle Kardiologie · doi:10.1055/a-2181-8122

Antithrombotische Therapie

Wille, H. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_9

Effects of Salvianolate Injection on the Pharmacodynamics and Pharmacokinetics of Warfarin in Rats In vivo

Zhao, Y., Sun, J., Xu, S., Liu, Y., Qin, M., Yang, C., & Liu, G. (2024) · Current Analytical Chemistry · doi:10.2174/0115734110289980240201073715

Tüm Yönleri ile AF ve Tedavi Yaklaşımları

Çelik, A., Hakgör, A., Çolak, A., Kunak, A. Ü., Sezenöz, B., Şengör, B. G., Arın, C. B., Coşkun, E. Ç., Ersoy, E. I. Y., Aksakal, E., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.1962

ATRIAL FIBRILLATION IN PATIENTS WITH CANCER (ANALYSIS OF LITERARY SOURCES)

Федорец, В. Н., Вологдина, И. В., Василенко, В. С., Григорьевна, П. Е., & Красильникова, Л. А. (2023) · Медицина: теория и практика · doi:10.56871/mtp.2023.43.39.002

A anticoagulação no Sistema Único de Saúde: relato de experiência

Silva, L. C., Caixeta, D. E. S., & Zago, L. B. R. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e15938.2024

The Impacts of Oral Anticoagulants on Clinical Outcomes in Patients with Atrial Fibrillation Across Five Stages of Renal FunctionPreprint

Liao, J., Chan, Y., Lee, H., Yeh, Y., Chang, S., Chen, S., & Chao, T. (2024) · medRxiv · doi:10.1101/2024.04.15.24305865

Fibrilación auricular de novo en síndrome coronario agudo

Trujillo-Flores, D., & García-Mendoza, J. D. J. (2024) · Archivos de cardiología de México · doi:10.24875/acm.23000008

Antikoagulation bei abnormer Nierenfunktion oder Dialyse

Brandenburg, V. M., & Heine, G. H. (2024) · Nephrologie aktuell · doi:10.1055/a-2215-3704

Perioperatives Management der oralen Antikoagulation

Thiele, T., & Länger, F. P. (2024) · Allgemein- und Viszeralchirurgie up2date · doi:10.1055/a-2225-8914

A pilot study to evaluate the quality of care in oral anticoagulant and antiplatelet use in patients with permanent atrial fibrillation in Irish general practice

McErlean, S., Broughan, J., McCombe, G., Fawsitt, R., Cullen, W., & Gallagher, J. (2024) · Primary Health Care Research & Development · doi:10.1017/s1463423623000622

Évaluation pharmaceutique des risques de prescription des anticoagulants oraux directs chez le patient atteint de cancer

Giraud, J.-S., Berge, M., Sardelli, J., Boudou, P., Batista, R., Puszkiel, A., Blanchet, B., Jouinot, A., Goldwasser, F., & Thomas‐Schoemann, A. (2024) · Le Pharmacien Clinicien · doi:10.1016/j.phacli.2024.04.425

Periprocedural Edoxaban Management and Clinical Outcomes in Patients Undergoing Transcatheter Cardiovascular Procedures in the EMIT-AF/VTE Program

Unverdorben, M., Colonna, P., Jin, J., Köhler, S., Santamaría, A., Saxena, M., Borrow, A. P., Chen, C., von Heymann, C., & Vanassche, T. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241260728

Left atrial appendage closure

O'Leary, G. M. (2024) · Nursing Made Incredibly Easy! · doi:10.1097/nme.0000000000000054

Fragilidade e Fibrilação Atrial: Um Olhar Mais Atento ao Estudo FRAIL-AF

Ferreira, R. M. (2024) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230671 · Cited by 3

The Role of Direct Oral Anticoagulants in Managing Myeloproliferative Neoplasms PatientsPreprint

Bang, S.-M., Lee, J. Y., Lee, J. H., Park, W., Seo, J., Kang, M.-S., Jung, E. H., Kim, S., Suh, K. J., Kim, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4602741/v1

Anticoagulant therapy today: from DOACS to factor XI inhibitors

Tondi, P., & Pola, R. (2024) · Acta Phlebologica · doi:10.23736/s1593-232x.24.00635-0

Atrial fibrillation de novo in acute coronary syndrome

Trujillo-Flores, D., & García-Mendoza, J. D. J. (2024) · Archivos de cardiolog�a de M�xico (English ed Internet) · doi:10.24875/acme.m24000486

Facial trauma with life-threatening bleeding treated by andexanet alfa administration: A case report

Shirakawa, Y., Jingami, N., Ishiguro, Y., Minami, T., Shinozuka, K., Yunoki, T., & Ohtsuru, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36922

Specific Reversal Agents for Direct Oral Anticoagulants in Acute Stroke

Frol, S., Oblak, J. P., Šabović, M., van Zwam, W. H., Ntaios, G., Lövblad, K., Gruber, A., & Kermer, P. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241279545

Gestion périopératoire des agents antiplaquettaires

Bounes, F. V., Godiér, A., & Roullet, S. (2024) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2024.04.004

Terapias Anticoagulantes Modernas para Fibrilação Atrial: Uma Revisão Atual

Neto, R. O. C., Resende, R. S., Souza, D. C. P., SPAHY, L. L., Hernandez, R. T., Ferreira, Y. L., Neto, C. M. D. S., de Souza, G. S., Amaral, H. E. F., MOURA, L. S. D. A., et al. (2024) · Brazilian Journal of Implantology and Health Sciences · doi:10.36557/2674-8169.2024v6n9p364-380

Prophylaxe thromboembolischer Komplikationen

Kleinschmidt, S. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-45539-5_29-2

Competing stroke mechanisms despite adequate oral anticoagulant therapy: the role of transesophageal echocardiography

Paolucci, M., Riva, L., Gentile, L., Fanciulli, C., Forlivesi, S., Gentile, M., Viola, M. M., Bugani, G., Casella, G., & Zini, A. (2024) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001673

Biological Variation of Hemostasis Analytes in Atrial Fibrillation Patients Using Dabigatran

Tilly, M. J., Donkel, S. J., Kavousi, M., de Groot, N. M. S., & de Maat, M. P. M. (2024) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfae116

Predictors and Outcomes of Inappropriate Dosing of Direct Oral Anticoagulants in Patients Receiving Transcatheter Aortic Valve Implantation

Amoey, D., Samy, M., Elbasha, K., Alali, A., Landt, M., Kurniadi, A., NEF, H. M., Tölg, R., Richardt, G., & Mankerious, N. (2024) · Cardiology and Therapy · doi:10.1007/s40119-024-00387-0

Intake Patterns and Experiences of Patients Using Direct Oral Anticoagulants Measured by Electronic Monitoring in Community Pharmacies

Desmaele, S., Capiau, A., Grymonprez, M., Pironet, A., Steurbaut, S., & Rydant, S. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s469910

Perioperatives Management der oralen Antikoagulation

Thiele, T., & Länger, F. P. (2024) · OP-Management up2date · doi:10.1055/a-2442-9673

Regionalanästhesie und antithrombotische Therapie

Glaeser-Quintus, M. (2024) · Anästhesie Nachrichten · doi:10.1007/s44179-024-00266-y

Phenotypes of Patients with Direct Oral Anticoagulant (DOAC) Underdosing in Atrial Fibrillation: Results from the ARENA Registry

Brockmueller, C., Meid, A. D., Senges, J., Hochadel, M., Haefeli, W. E., & Stoll, F. (2024) · Clinical Drug Investigation · doi:10.1007/s40261-024-01411-w

Factors that Contribute to the Failure of Thromboprophylaxis in Patients with Atrial Fibrillation: A Hospital-Based Cross-Sectional Study

Wu, Y., Shi, J., Jiao, J., Shen, Y., Zhang, D., Wang, Z., Li, M., & Chen, M. (2024) · International Journal of Heart Rhythm · doi:10.4103/ijhr.ijhr_2_24

Warfarin Versus Non–Vitamin K Inhibitor Medications and Cognitive Disease Progression in Atrial Fibrillation

Wood, K., Ko, Y., Han, F., Thunell, J. A., Zissimopoulos, J., & Wharton, W. (2024) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000001159

Direct Oral Anticoagulants Versus Vitamin K Antagonists in Chronic Kidney Disease Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis

Mejia, R. R., Singh, A., Bahekar, A., & Kammaripalle, T. K. C. (2025) · Cureus · doi:10.7759/cureus.79052

Clinical and Economic Impact of a First Major Bleeding Event in Non-Anticoagulated Patients in Spain: A 3-Year Retrospective Observational Cohort Study

Escobar, C., Palacios, B., Villarreal, M., Gutiérrez, M., Capel, M., Hernández, I., García, M., Bryant, L. L., & Arenillas, J. F. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14041377

Periprozedurales Management unter antithrombotischer Therapie

Bauersachs, R. M. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-61379-5_159-1

Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillation

SATO, T. A., Dai, Z., Hashimoto, J., Ohde, S., Komiyama, N., Inomata, T., & Yamauchi, T. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319342

Prescriptions of CYP3A4‐ and P‐gp inducers for patients on direct oral anticoagulants: Bridging the gap between epidemiology and patient management for optimal thromboembolic event prevention

Wuyts, S. C. M., Moor, J. D., Jochmans, K., Cortoos, P., Vandervorst, F., Steurbaut, S., Dupont, A. G., & Cornu, P. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70007 · Cited by 1

Evaluating Major Bleeding Risks with Concomitant Use of Direct Oral Anticoagulants and Selective Serotonin Reuptake Inhibitors in Nonvalvular Atrial Fibrillation Patients

Yao, S.-Y., Kocis, P. T., Murphy, T. E., & Hwang, W. (2025) · Pharmacoepidemiology · doi:10.3390/pharma4010006

Navigating the Complexity: Management of Acute Myocardial Infarction With Intracranial Hemorrhage

Bolaji, O., Bahar, Y., Shah, R. P., Bahar, Y., Oriaifo, O. F., Lawrence, I., Adabale, O. K., Mohamed, W., & Alraies, M. C. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000000889

Pericardial Effusion Associated With Direct Oral Anticoagulant Use in a Single Center Experience

Song, J., Jaradeh, M., Xu, W., Deluna, A., Sevak, R. J., Wang, C., & Zhao, S. X. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101612

Dementia-related adverse events associated with direct oral anticoagulants use: a real-world, pharmacovigilance study based on the FAERS database

Zhang, H., Li, M., Liu, W., & Yuan, H. (2025) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2025.2490847

Frailty in patients with atrial fibrillation: diagnosis, management, prevention and influence on prognosis

Станиславовна, К. Е., Dashaeva, M. I., & Панченко, Е. П. (2025) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin2025200115

Management and Outcomes of Intracranial Hemorrhage in Atrial Fibrillation Patients: Highlighting Practices in Saudi Arabia

Alghamdi, A. M., Alkulli, O. A., Fatani, F., Subahi, F. S., Tayeb, A. F., Alghamdi, A., Alzahrani, M. T., & Almehmadi, F. (2025) · Cureus · doi:10.7759/cureus.82813

Concurrent Apixaban With Itraconazole or Posaconazole Pharmacokinetic and Clinical Outcome Evaluation in Cardiothoracic Transplant Recipients

Concannon, K., Huntsman, R., Mara, K. C., Kennedy, C. C., Rosenbaum, A. N., & Lemke, A. I. (2025) · Clinical Transplantation · doi:10.1111/ctr.70165

Antithrombotische Therapie

Mühlbauer, B., & Wille, H. (2025) · Springer eBooks · doi:10.1007/978-3-662-70594-0_9 · Cited by 1

Hospital-to-facility transitions for antithrombosis patients: Perilous junctures requiring focused stewardship

Booker, C. N., Sarangarm, P., Kooiman, J., Huynh, T., Lujan, S., Chiu, T., Patton, R., & Burnett, A. (2025) · Journal of Patient Safety and Risk Management · doi:10.1177/25160435251340242

Anticoagulation in cirrhosis

Roberts, L. N. (2025) · Frontline Gastroenterology · doi:10.1136/flgastro-2024-102994

Left atrial appendage closure in patients with prior intracranial bleeding, safety, efficacy, and timing

Calle, D. G., y, L. N.-F., Gutiérrez-García, H., Peral, V., Mesnier, J., Tirado-Conde, G., Barrero-Mier, A. F., Gonzalez, A. M., O’Hara, G. E., López-Mesonero, L., et al. (2025) · Neurología · doi:10.1016/j.nrl.2023.11.012

Antithrombotische Behandlung nach intrazerebraler Blutung

Völzke, E. (2025) · DGNeurologie · doi:10.1007/s42451-025-00758-4

The Influence of Renal Function on Safety and Effectiveness of Oral Anticoagulant Treatment among Frail Elderly Patients with Non-Valvular Atrial Fibrillation and Chronic Kidney Disease

Qutub, M. A., Algazzar, A. S., Alassiri, A. K., Albukhari, S. A., Bokhary, A. H., Almarghany, A. A., Elsayed, A., & Elbably, M. M. (2025) · Cardiology · doi:10.1159/000546865

Management of Bleeding in Patients on Vitamin K Antagonists

Poli, D., & Prisco, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-89214-1_9

Dealing with oral anticoagulants in stroke patients: A narrative review based on current practice guidelines

Goel, D., & Singh, P. (2025) · Brain Circulation · doi:10.4103/bc.bc_151_24

Population pharmacokinetics of edoxaban in geriatric patients with atrial fibrillation

Edwina, A. E., der Linden, L. R. V., Debruyne, L., Foerster, K. I., Burhenne, J., Verhamme, P. B., Vanassche, T., Spriet, I., Dreesen, E., & Tournoy, J. (2025) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2025.06.023

Optimization of vitamin K antagonist treatment: Near patient monitoring versus standard of care a parallel group clinical trial in older patients with atrial fibrillation

van Elp, M., Beinema, M. J., Brouwers, J. R. B. J., Riet, E. V. ‘., van de Leur, S. J. C. M., Schreiber, I., & Jansman, F. G. A. (2025) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-025-03878-8

Efficacy and safety of low-dose rivaroxaban in elderly patients with atrial fibrillation for oral anticoagulation therapy: Rationale, design, and study protocol for a multicenter randomized controlled trial (SAFE-AF)

Han, J., Qi, W., Yuan, S., Liu, H., Wang, Y., Zhang, H., Liu, J., Zhao, Y., Zhang, Y., Zheng, L., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.07.011

Apixaban for Cancer-Associated Venous Thromboembolism

Wu, G., Liu, W., & Sheung, L. (2025) · New England Journal of Medicine · doi:10.1056/nejmc2506526

Efficacy and Safety of Direct Oral Anticoagulants for Patients With Atrial Fibrillation With Glomerular Hyperfiltration: A Systematic Review and Meta-Analysis

Gao, X., Jia, Z., Tse, G., Lip, G. Y. H., & Liu, T. (2025) · Clinical Therapeutics · doi:10.1016/j.clinthera.2025.06.015

DOACs vs. VKAs for renal protection: An established superiority gives rise to a new clinical paradox

Shamsulddin, A. B. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.017

Study on the Efficacy and Safety of Off‐Label Dosing of Rivaroxaban in Chinese Nonvalvular Atrial Fibrillation Patients

Jiang, Z., Dong, W., Lu, X., Liu, X., & Gong, J. (2025) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1155/jcpt/5598614

Practical Comprehensive Approach to Current Atrial Fibrillation Challenges: Insights from an Expert Panel

Escobar, C., Camafort, M., Fortuny, E., Grymonprez, M., Cabeza, A. P., Backer, T. L. M. D., & Leaders Connect Group (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155199

Identification of risk factors and development of a predictive model in patients using cefmetazole for international normalized ratio elevation

Namiki, T., Yokoyama, Y., Kimura, M., Fukuda, S., Seyama, S., Iketani, O., Samura, M., Ishikawa, H., Jibiki, A., Kawazoe, H., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322909

Anticipation des problèmes pharmacothérapeutiques en amont de l’allogreffe (SFGM-TC)

Simon, N., Bonnin, A., Bail, A. J.-L., Masouridi‐Levrat, S., Forcade, É., Roch-Torreilles, I., Coiteux, V., Magro, L., & Bourgeois, A. L. (2025) · Bulletin du Cancer · doi:10.1016/j.bulcan.2025.04.014

Clinical Perspectives on Stroke Prevention in Patients with Non-valvular Atrial Fibrillation in the Philippines

Jiménez, R., Bernan, A. P., Cheng, F. C., Gan, H. H., García, M. V., Ong-Garcia, H. N., & Lim, J. (2025) · Cureus · doi:10.7759/cureus.90214

Ischaemic Stroke in Patients with Known Atrial Fibrillation: A Snapshot from a Large University Hospital Experience

Scrima, G. D., Sarti, C., Pracucci, G., Nistri, R., Rapillo, C. M., Piccardi, B., Stolcova, M., Ristalli, F., Mattesini, A., Nozzoli, C., et al. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176012

Vascular epilepsy in adulthood: current status and outlook for research and management

Stefan, H., Hammen, T., & Punia, V. (2025) · Clinical Epileptology · doi:10.1007/s10309-025-00782-0

Validation of a machine learning model for predicting gastrointestinal bleeding in patients with direct oral anticoagulants

Kim, I., Hou, J., Choe, J. H., Kim, J. S., Cheung, D. Y., & Kim, B. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2565321

Prevention of cardioembolism in atrial fibrillation

Mazya, M. V., & Simonsson, M. (2025) · doi:10.1002/9781394223152.ch21

Response to comment on “Impact of amiodarone on plasma concentration of direct oral anticoagulant in patients with atrial fibrillation”

Lin, S., Liu, S.-Y., Wang, C., & Tang, S. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.09.034

Acute Renal Artery Thrombosis Following Delayed Postoperative Anticoagulation in Atrial Fibrillation: A Case Report Supporting Apixaban Monotherapy

Kureemun, M. R., Rahemtoola, M. S., Husein, A. A. I., & Dalmia, S. (2025) · Cureus · doi:10.7759/cureus.93720

Protocolo de cardioversión eléctrica

Fraile, P. Z., Castellano, N. P., Cuervo, D. C., Rama, D. F., & Villacastín, J. P. (2025) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2025.09.015

Peak and Trough Concentration Ranges of Factor Xa Inhibitors for Preventing Thromboembolic Stroke in Korean Patients with Non-valvular Atrial Fibrillation

Park, J. S., Lim, K., Kim, D., Lee, K. M., Woo, K., & Han, J. (2025) · Annals of Laboratory Medicine · doi:10.3343/alm.2025.0144

Month-Long Unclotted Hemoperitoneum on Edoxaban Confirmed by Laparoscopy: A Case Report

Miyaoka, Y., Shimada, S., Yoshida, Y., Yokoyama, R., & Taketomi, A. (2025) · Cureus · doi:10.7759/cureus.94618

Direct oral anticoagulant use in under‐represented populations with atrial fibrillation: a survey of Australian pharmacist practice

Lai, B., Ziser, K. E. D., Appay, M., Potts, C., & Livori, A. (2025) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr.70043

Antithrombotic management in left sided- ablation and appendage device-closure procedures

Mathai, S. V., Zou, F., & Biase, L. D. (2025) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2025.10.008

Oral anticoagulation therapy in the setting of liver disease

SALMON, T. W., & Lip, G. Y. H. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2580358

Dispositivos en insuficiencia cardíaca: rol del desfibrilador automático implantable y la terapia de resincronización cardíaca

Cruz, P. F., Peltzer, M., & Gac, J. (2025) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2025.10.007

Effect of lunar phases on international normalized ratio in patients with deep vein thrombosis using warfarin

Orhan, A., & Şengül, F. (2025) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_170_25

Reference range of rivaroxaban‐calibrated anti‐Xa activity in Chinese children with giant coronary artery aneurysms after KawasakI disease: insights from a population pharmacokinetic and pharmacodynamic analysis

Liu, B., Dai, G., Xu, N., Liu, X., Mak, W. Y., Zhang, L., Brandão, L. R., Huang, G., Liu, F., & Zhu, X. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70324

Pharmacology of Anticoagulation

Merli, G. J., & Thomson, L. J. (2025) · Springer eBooks · doi:10.1007/978-3-030-70904-4_7-1

Dose Optimization of Rivaroxaban in Elderly Chinese Patients with Non-Valvular Atrial Fibrillation: Analysis of Populations Pharmacokinetics and Exposure-Response Relationships

Li, T., Liu, X., Tang, L., Cai, W., Zhang, J., Su, Y., Yu, C., Liu, B., Jiang, L., Liu, C., et al. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s563521

Postoperative Bleeding After Dental Implant Surgery in Patients on Direct Oral Anticoagulants: A Retrospective Case–Control Study

Manor, Y., Ben-Izhack, G., Manor, P. A., Peleg, O., & Reiter, S. (2025) · Dentistry Journal · doi:10.3390/dj13120576

Oral Anticoagulation Therapy After Acute Coronary Syndrome

Chan, N., & Eikelboom, J. W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11869-2.00025-4

Impact of different doses of rivaroxaban on clinical outcomes in elderly patients with non-valvular atrial fibrillation: a real-world study

Yu, J., Zhang, Z., Yuan, Q., Hu, H., Li, H., Huang, M., & Mao, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1714318

Real-World Comparative Study of Ultra-Low-Dose Rivaroxaban in Very Elderly Patients with Atrial Fibrillation

Han, D., Ni, Q., Qi, J., Ni, H., & Wang, B. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s555943

Cardiac, Perioperative Risk Assessment

Klein, K., & Kelm, M. (2025) · Springer eBooks · doi:10.1007/978-3-662-69938-6_44

Additional file 5 of Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey

Sijpe, G. V. D., Quintens, C., Walgraeve, K., laer, E. V., Penny, J., Vlieger, G. D., Schrijvers, R., Munter, P. D., Foulon, V., Casteels, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19218954

Additional file 4 of Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences

Khouja, C., Brunton, G., Richardson, M. A., Stokes, G., Blanchard, L., Burchett, H., Khatwa, M., Walker, R., Wright, K. E., Sowden, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21427304

Additional file 1 of Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey

Sijpe, G. V. D., Quintens, C., Walgraeve, K., laer, E. V., Penny, J., Vlieger, G. D., Schrijvers, R., Munter, P. D., Foulon, V., Casteels, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19218936

Additional file 2 of Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences

Khouja, C., Brunton, G., Richardson, M. A., Stokes, G., Blanchard, L., Burchett, H., Khatwa, M., Walker, R., Wright, K. E., Sowden, A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21427298

Additional file 6 of Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey

Sijpe, G. V. D., Quintens, C., Walgraeve, K., laer, E. V., Penny, J., Vlieger, G. D., Schrijvers, R., Munter, P. D., Foulon, V., Casteels, M., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19218957

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

Steffel, J., Verhamme, P., Potpara, T. S., Albaladejo, P., Antz, M., Desteghe, L., Haeusler, K. G., Oldgren, J., Reinecke, H., Roldan-Schilling, V., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy136 · Cited by 2,123

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

Steffel, J., Verhamme, P. B., Potpara, T., Albaladejo, P., Antz, M., Desteghe, L., Hæusler, K. G., Oldgren, J., Reinecke, H., Roldán, V., et al. (2018) · EP Europace · doi:10.1093/europace/euy054 · Cited by 248

Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart Rhythm Association Practical Guide)

Popova, L. V., Борисовна, К. Т., Аксенова, М. Б., Васильевна, Х. Т., & Kanevskaya, M. (2019) · Kardiologiia · doi:10.18087/cardio.2019.5.2633 · Cited by 3

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,129

Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., Kirchhof, P. F., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw058 · Cited by 272